Welcome to Entry Card of Peptide


Details of TopicalPdb ID 1377

PRIMARY INFORMATION
ID1377
PMID21291377
Year2011
SequenceCDLPQTHSLGSRRTLM
LLAQMRKISLFSCLKD
RHDFGFPQEEFGNQFQ
KAETIPVLHEMIQQIF
NLFSTKDSSAAWDETL
LDKFYTELYQQLNDLE
ACVIQGVGVTETPLMK
EDSILAVRKYFQRITL
YLKEKKYSPCAWEVVR
AEIMRSFSLSTNLQES
LRSKE
NameInterferon Alpha (IFN α)
Length165
N-Terminal ModificationFree
C-Terminal ModificationFree
Linear/ CyclicCyclic (C1-C98, C29-138)
ChiralityL
Chemical ModificationGylcosylation at 82th residue
Origin of PeptideInterferon Alpha (IFN α)
Nature of Peptide/CargoAntiviral, antiproliferative, and immunomodulatory properties
MechanismNot mentioned
Cargo Sequence/StructureNone
Name of cargo
Not applicable
AssayELISA and antiviral assay
EnhancerTopical reservoir-type round patches were used for transdermal delivery. Biphasic vesicles preparations with 0, 5, 15, or 40MIU IFN α were placed into the cavity of the patch.
Properties of enhancerNot mentioned
Concentration5 MIU IFN α
Incubation time48 hours
Tissue permeability (value with units)Antiviral assay showed an average IFN α levels of 380±60 IU/mg protein in skin homogenate. ELISA of skin homogenate increased the IFNα levels from <12.5pg/mg tissue to 122.4±25.9 pg/mg tissue.
Tissue SampleHuman skin biopsy samples
Ex vivo/In vivo/In vitroin vivo
SECONDARY INFORMATION
STRUCTURE
Predicted Structure
SMILESN.A.